XML 27 R17.htm IDEA: XBRL DOCUMENT v3.4.0.3
SHAREHOLDERS' EQUITY (Tables)
 3 Months Ended
Mar. 31, 2016
Stockholders' Equity Note [Abstract]  
Schedule of Stock Option Activity
    Number of options(in thousands)     Weighted-average exercise price    

Weighted- average remaining contractual term

 (in years)

     Aggregate intrinsic value  
                         
Outstanding at December 31, 2015     856,986     $ 7.75       3.28     $ 6,157  
Granted     -       -                  
Exercised     (98,261 )     7.63                  
Expired & Forfeited     (2,500 )     10.04                  
                                 
Outstanding at March 31, 2016     756,225     $ 7.75       3.18     $ 4,539  
                                 
Vested and expected to vest at  March 31, 2016     756,225     $ 7.75       3.18     $ 4,539  
                                 
Exercisable at March 31, 2016     653,100     $ 7.29       2.98     $ 4,198  
Schedule of RSUs
    Number of RSUs     Weighted average remaining contractual term (in years)     Aggregate intrinsic value  
                   
Outstanding at December 31, 2015     15,500       0.1     $ 231  
Granted     28,000                  
Vested     (8,500 )                
Cancelled & forfeited     -                  
                         
Outstanding at March 31, 2016     35,000       0.05     $ 479  
                         
Vested and expected to vest at March 31, 2016     35,000       0.05     $ 479  
Stock Options Under the Plans by Exercise Price
   

Options outstanding

at March 31, 2016

    

Options exercisable

at March 31, 2016

  
Exercise price   Number outstanding     Weighted average exercise price     Weighted average remaining contractual life     Number exercisable     Weighted average exercise price     Weighted average remaining contractual life  
$           $     In years           $     In years  
                                     
1.87 - 1.95     3,550       1.89       0.63       3,550       1.89       0.63  
2.56 - 4.86     220,300       3.56       2.42       200,300       3.60       2.31  
5.0 – 9.64     200,625       6.06       3.23       199,250       6.03       3.22  
10.49 – 14.52     331,750       11.63       3.68       250,000       11.33       3.36  
                                                 
      756,225                       653,100                  
Departmental Allocation of Share-based Compensation Charge
   

Three months ended

March 31,

  
    2016 *)     2015 *)  
    Unaudited  
             
Cost of revenue   $ 14     $ 9  
Research and development, net     171       165  
Selling and marketing, net     20       91  
General and administrative     232       119  
                 
    $ 437     $ 384  

 

*) Including $143 and $0 compensation cost related to RSUs for the three month periods ended March 31, 2016 and 2015, respectively.
Outstanding Warrants and Rights
Issuance date   Outstanding and exercisable   Exercise price   Exercisable through
April 24, 2013   135,537   3.49   July 2, 2016
April 24, 2013    175,448*   3.49   May 5, 2016

 

*)  On February 29, 2016, the Company received $417 from the exercise of 119,474 warrants to purchase 119,474 of the Company's Ordinary Shares; as of March 31, 2016, the 119,474 Ordinary Shares have not been issued and the $417 has been recorded as a receipt on account of shares. Subsequent to the Balance Sheet date, the 119,474 Ordinary Shares issued and an additional 55,974 warrants were exercised to purchase 55,974 of the Company's Ordinary Shares for additional total consideration of $195.